These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 24760630)

  • 1. Hepatocellular carcinoma in Budd-Chiari syndrome: enhancement patterns at dynamic gadolinium-enhanced T1-weighted MR imaging.
    Yang C; Xu K; Zheng J; Ma P; Hu C; Li S; Rong Y; Lu X; Zhang Q; Zu M; Hua R; Zhang L
    Cell Biochem Biophys; 2014 Sep; 70(1):661-6. PubMed ID: 24760630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocellular carcinoma in cirrhosis: enhancement patterns at dynamic gadolinium- and superparamagnetic iron oxide-enhanced T1-weighted MR imaging.
    Lutz AM; Willmann JK; Goepfert K; Marincek B; Weishaupt D
    Radiology; 2005 Nov; 237(2):520-8. PubMed ID: 16192317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocellular carcinoma in North America: a multiinstitutional study of appearance on T1-weighted, T2-weighted, and serial gadolinium-enhanced gradient-echo images.
    Kelekis NL; Semelka RC; Worawattanakul S; de Lange EE; Ascher SM; Ahn IO; Reinhold C; Remer EM; Brown JJ; Bis KG; Woosley JT; Mitchell DG
    AJR Am J Roentgenol; 1998 Apr; 170(4):1005-13. PubMed ID: 9530051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocellular carcinoma associated with Budd-Chiari syndrome: imaging features and transcatheter arterial chemoembolization.
    Liu FY; Wang MQ; Duan F; Fan QS; Song P; Wang Y
    BMC Gastroenterol; 2013 Jun; 13():105. PubMed ID: 23800233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New MR imaging criteria with a diffusion-weighted sequence for the diagnosis of hepatocellular carcinoma in chronic liver diseases.
    Piana G; Trinquart L; Meskine N; Barrau V; Beers BV; Vilgrain V
    J Hepatol; 2011 Jul; 55(1):126-32. PubMed ID: 21145857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of hepatocellular carcinoma in Egyptian patients with primary Budd-Chiari syndrome.
    Sakr M; Abdelhakam SM; Dabbous H; Hamed A; Hefny Z; Abdelmoaty W; Shaker M; El-Gharib M; Eldorry A
    Liver Int; 2017 Mar; 37(3):415-422. PubMed ID: 27507647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocellular carcinoma in the cirrhotic liver: double-contrast MR imaging for diagnosis.
    Ward J; Guthrie JA; Scott DJ; Atchley J; Wilson D; Davies MH; Wyatt JI; Robinson PJ
    Radiology; 2000 Jul; 216(1):154-62. PubMed ID: 10887242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic nodules in Budd-Chiari syndrome: imaging features.
    Vilgrain V; Lewin M; Vons C; Denys A; Valla D; Flejou JF; Belghiti J; Menu Y
    Radiology; 1999 Feb; 210(2):443-50. PubMed ID: 10207428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocellular carcinoma in Budd-Chiari syndrome: characteristics and risk factors.
    Moucari R; Rautou PE; Cazals-Hatem D; Geara A; Bureau C; Consigny Y; Francoz C; Denninger MH; Vilgrain V; Belghiti J; Durand F; Valla D; Plessier A
    Gut; 2008 Jun; 57(6):828-35. PubMed ID: 18218675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging features of subcentimeter hypointense nodules on gadoxetic acid-enhanced hepatobiliary phase MR imaging that progress to hypervascular hepatocellular carcinoma in patients with chronic liver disease.
    Jang KM; Kim SH; Kim YK; Choi D
    Acta Radiol; 2015 May; 56(5):526-35. PubMed ID: 24838304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocellular carcinoma: evaluation with dynamic and static gadobenate dimeglumine-enhanced MR imaging and histopathologic correlation.
    Vogl TJ; Stupavsky A; Pegios W; Hammerstingl R; Mack M; Diebold T; Lodemann KP; Neuhaus P; Felix R
    Radiology; 1997 Dec; 205(3):721-8. PubMed ID: 9393527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small (≤1-cm) hepatocellular carcinoma: diagnostic performance and imaging features at gadoxetic acid-enhanced MR imaging.
    Yu MH; Kim JH; Yoon JH; Kim HC; Chung JW; Han JK; Choi BI
    Radiology; 2014 Jun; 271(3):748-60. PubMed ID: 24588677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute Budd-Chiari syndrome associated with non-viral cryptogenic hepatocellular carcinoma: revisiting the 'chicken or the egg' theory.
    Søreide K
    Hepatogastroenterology; 2014; 61(130):388-90. PubMed ID: 24901147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hepatic and hepatocarcinoma magnetic resonance: comparison of the results obtained with paramagnetic (gadolinium) and superparamagnetic (iron oxide particles) contrast media].
    Castoldi MC; Fauda V; Scaramuzza D; Vergnaghi D
    Radiol Med; 2000 Sep; 100(3):160-7. PubMed ID: 11148882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MR imaging features and long-term evolution of benign focal liver lesions in Budd-Chiari syndrome and Fontan-associated liver disease.
    Panvini N; Dioguardi Burgio M; Sartoris R; Maino C; Van Wettere M; Plessier A; Payancé A; Rautou PE; Ladouceur M; Vilgrain V; Ronot M
    Diagn Interv Imaging; 2022 Feb; 103(2):111-120. PubMed ID: 34654671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocellular carcinoma in the cirrhotic liver: gadolinium-enhanced 3D T1-weighted MR imaging as a stand-alone sequence for diagnosis.
    Hecht EM; Holland AE; Israel GM; Hahn WY; Kim DC; West AB; Babb JS; Taouli B; Lee VS; Krinsky GA
    Radiology; 2006 May; 239(2):438-47. PubMed ID: 16641353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can the patient with cirrhosis be imaged for hepatocellular carcinoma without gadolinium?: Comparison of combined T2-weighted, T2*-weighted, and diffusion-weighted MRI with gadolinium-enhanced MRI using liver explantation standard.
    Hardie AD; Kizziah MK; Rissing MS
    J Comput Assist Tomogr; 2011; 35(6):711-5. PubMed ID: 22082541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benign hepatic nodules in Budd-Chiari syndrome: radiologic-pathologic correlation with emphasis on the central scar.
    Maetani Y; Itoh K; Egawa H; Haga H; Sakurai T; Nishida N; Ametani F; Shibata T; Kubo T; Tanaka K; Konishi J
    AJR Am J Roentgenol; 2002 Apr; 178(4):869-75. PubMed ID: 11906865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and pathological features and surgical treatment of Budd-Chiari syndrome-associated hepatocellular carcinoma.
    Wang YD; Xue HZ; Zhang X; Xu ZQ; Jiang QF; Shen Q; Yu M; Li K; Jia M
    Chin Med J (Engl); 2013; 126(19):3632-8. PubMed ID: 24112155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The dynamic magnetic resonance study of focal liver lesions by FLASH sequences with bolus intravenous gadolinium-DTPA].
    Olivetti L; Grazioli L; Maroldi R; Matricardi L; Milanesio L
    Radiol Med; 1992 Apr; 83(4):353-60. PubMed ID: 1318558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.